Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | AZD9574 |
Synonyms | |
Therapy Description |
AZD9574 is a PARP1 inhibitor that can penetrate the blood-brain barrier, potentially leading to inhibition of tumor growth (PMID: 37967136). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
AZD9574 | AZD-9574|AZD 9574 | PARP-1 Inhibitor 10 | AZD9574 is a PARP1 inhibitor that can penetrate the blood-brain barrier, potentially leading to inhibition of tumor growth (PMID: 37967136). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05417594 | Phase Ib/II | AZD9574 AZD9574 + Temozolomide | Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies (CERTIS1) | Recruiting | USA | SWE | GBR | ESP | DEU | AUS | 1 |